22Jan
Blog: Cooley’s 2020 Life Sciences M&A Year in Review
General Trends in Life Sciences M&A - If 2019 was the year of life sciences mega-deals, 2020 was the year of COVID-19, as the global pandemic permeated every aspect of the dealmaking landscape, with the life sciences sector being no exception. COVID-19 drove unprecedented levels of collaboration among biopharmaceutical companies seeking to develop a vaccine, leading to an accelerated research and development process that allowed not just one—but two—vaccines to be approved by the FDA in...
By:
Cooley LLP
Related
U.S. immigration law is a complicated legal area that requires the services of exceptional employmen...
Read More >
Join Maya Hamouie and Gabriela Pérez on December 5, 2019 for “ABC to AB 5: Changes to Independent C...
Read More >
The last week has been filled with news broadcasts, jokes, and general discussion of the use of a Sh...
Read More >
The U.S. Department of Justice and Federal Trade Commission on June 30, 2020, published in final fo...
Read More >
As the COVID-19 pandemic has raged on, financial institutions and banks have withstood its effects a...
Read More >
Over the course of the past several years, several states have banned or severely restricted the abi...
Read More >